학술논문
A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer’s disease
Document Type
Article
Author
Prins, N.D.; Harrison, J.E.; Scheltens, P.; Chu, H.-M.; Blackburn, K.; Alam, J.J.; Arnold; Coskinas; Gonzales; Joseph; Khan; McConnehey; Paricio; Taylor; Rowell, Z.; Groom; Summers; White; Thein; Bolouri; Schwartz; Vasquez; Asher; Ball; Munthali; Kabir; Langford; Komuravelli; Lynch; MacSweeney; Pearson; Faulkner; Miller; Underwood; Prins; Dautzenberg; Norden, V.; Pazdera; Bar; Dvacka; Valis; Votypkova; Areovimata; Justesen; Schmidt
Source
In: Alzheimer's Research and Therapy . (Alzheimer's Research and Therapy, December 2021, 13(1))
Subject
Language
English
ISSN
17589193